Is there a validated risk prediction model you favor to risk stratify patients for cardiotoxicity prior to initiation of chemotherapy?

I would recommend the HFA-ICOS risk calculator as recommended by the 2022 ESC/ICOS Cardio-Oncology guidelines. There is a great discussion here:

Strategies for risk stratification and cardiovascular toxicity prevention in patients with cancer

And there is an easy-to-use version online and on the ESC Pocket Guideline App. At the recent MSK Cardio-Oncology CME course one of the main guideline authors, Dr. Teresa Lopez Fernandez nicely reviewed the guidelines and how to incorporate this risk stratifi...